Branko Dmitrović

Branko Dmitrović

Auto-generated profile, based on publicly available information

Branko Dmitrović

Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2011 in Cancer Research
Verified
Journal Article
Closed access
PDF file
LDLaurent Dumartin
Laurent Dumartin
HWHannah J. Whiteman
Hannah J. Whiteman
MWMark E. Weeks
Mark E. Weeks
DHDeepak Hariharan
Deepak Hariharan
BDBranko Dmitrovic
Branko Dmitrovic
TCTatjana Crnogorac-Jurcevic
Tatjana Crnogorac-Jurcevic
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers largely due to disseminated disease at the time of presentation. Here, we investigated the role and mechanism of action of the metastasis-associated protein anterior gradient 2 (AGR2) in the pathogenesis of pancreatic cancer. AGR2 was induced in all sporadic and familial pancreatic intraepithelial precursor lesions (PanIN), PDACs, circulating tumor cells, and metastases studied. Confocal microscopy and flow cytometric analyses indicated that AGR2 localized to the endoplasmic reticulum (ER) and the external surface of tumor cells. Furthermore, induction of AGR2 in tumor cells regulated the expression of several ER chaperones (PDI, CALU, RCN1), proteins of the ubiquitin-proteasome degradation pathway (HIP2, PSMB2, PSMA3, PSMC3, and PSMB4), and lysosomal proteases [cathepsin B (CTSB) and cathepsin D (CTSD)], in addition to promoting the secretion of the precursor form pro-CTSD. Importantly, the invasiveness of pancreatic cancer cells was proportional to the level of AGR2 expression. Functional downstream targets of the proinvasive activity of AGR2 included CTSB and CTSD in vitro, and AGR2, CTSB, and CTSD were essential for the dissemination of pancreatic cancer cells in vivo. Taken together, the results suggest that AGR2 promotes dissemination of pancreatic cancer and that its cell surface targeting may permit new strategies for early detection as well as therapeutic management. Cancer Res; 71(22); 7091–102. ©2011 AACR.

28 January 2019 in Molecular Oncology
Verified
Journal Article
Open access
PDF file
WAWasfi Alrawashdeh
Wasfi Alrawashdeh
RJRichard Jones
Richard Jones
LDLaurent Dumartin
Laurent Dumartin
TRTomasz P. Radon
Tomasz P. Radon
PCPedro R. Cutillas
Pedro R. Cutillas
TCTatjana Crnogorac-Jurcevic
Tatjana Crnogorac-Jurcevic
Perineural invasion (PNI) is a common and characteristic feature of pancreatic ductal adenocarcinoma (PDAC) that is associated with poor prognosis, tumor recurrence, and generation of pain. However, the molecular alterations in cancer cells and nerves within PNI have not previously been comprehensively analyzed. Here, we describe our proteomic analysis of the molecular changes underlying neuro‐epithelial interactions in PNI using liquid chromatography–mass spectrometry (LC‐MS/MS) in microdissected PNI and non‐PNI cancer, as well as in invaded and noninvaded nerves from formalin‐fixed, paraffin‐embedded PDAC tissues. In addition, an in vitro model of PNI was developed using a co‐culture system comprising PDAC cell lines and PC12 cells as the neuronal element. The overall proteomic profiles of PNI and non‐PNI cancer appeared largely similar. In contrast, upon invasion by cancer cells, nerves demonstrated widespread plasticity with a pattern consistent with neuronal injury. The up‐regulation of SCG2 (secretogranin II) and neurosecretory protein VGF (nonacronymic) in invaded nerves in PDAC tissues was further validated using immunohistochemistry. The tested PDAC cell lines were found to be able to induce neuronal plasticity in PC12 cells in our in vitro established co‐culture model. Changes in expression levels of VGF, as well as of two additional proteins previously reported to be overexpressed in PNI, Nestin and Neuromodulin (GAP43), closely recapitulated our proteomic findings in PDAC tissues. Furthermore, induction of VGF, while not necessary for PC12 survival, mediated neurite extension induced by PDAC cell lines. In summary, here we report the proteomic alterations underlying PNI in PDAC and confirm that PDAC cells are able to induce neuronal plasticity. In addition, we describe a novel, simple, and easily adaptable co‐culture model for in vitro study of neuro‐epithelial interactions.

14 November 2011 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
KNKalnisha Naidoo
Kalnisha Naidoo
RJRichard Jones
Richard Jones
BDBranko Dmitrovic
Branko Dmitrovic
NWNilukshi Wijesuriya
Nilukshi Wijesuriya
Hemant M KocherHemant M Kocher
Hemant M Kocher
TCTatjana Crnogorac-Jurcevic
Tatjana Crnogorac-Jurcevic

1 April 2012 in The American Journal of Pathology
Verified
Journal Article
Closed access
KLKate Lines
Kate Lines
Claude ChelalaClaude Chelala
Claude Chelala
BDBranko Dmitrovic
Branko Dmitrovic
NWNilukshi Wijesuriya
Nilukshi Wijesuriya
Hemant M KocherHemant M Kocher
Hemant M Kocher
TCTatjana Crnogorac-Jurcevic
Tatjana Crnogorac-Jurcevic

29 March 2017 in BMC Cancer
Verified
Journal Article
Open access
PDF file
SKSven Kurbel
Sven Kurbel
BDBranko Dmitrović
Branko Dmitrović
KMKsenija Marjanović
Ksenija Marjanović
DVDamir Vrbanec
Damir Vrbanec
AJAntonije Juretić
Antonije Juretić
Unexpected differences in Ki-67 values among HER2 & ER/PgR defined subgroups were found. This study aims to detect possible subdivisions beyond the conventional breast cancer types. One thousand one hundred eighty consecutive patients with invasive ductal breast carcinoma were included and distributed in 16 subgroups (four HER2 phenotypes (0+, 1+, 2+ and 3+) times four ER/PgR phenotypes). Complex distributions of Ki-67 values were tested by expectation maximization (EM) clustering. Pooled Ki67 values of all patients showed the presence of three EM clusters (defined as LMA-low mitotic activity, IMA-intermediate mitotic activity and HMA-high mitotic activity) with expected mean Ki-67 values of 1.17%, 40.45% and 77.79%, respectively. Only ER-PgR- tumors significantly dispersed in three clusters (29.75% tumors in LMA, 46.95% in IMA and 23.30% in the HMA cluster), while almost no detected HMA tumors were of ER + PgR+ or ER + PgR- phenotypes. Among 799 ER + PgR+ patients distribution in clusters was HER2 dependent (p = 0.000243), due to increased number of IMA HER2 3+ tumors on the expense of LMA HER2 3+ tumors (52 IMA out of 162 HER2 3+ patients versus113 IMA out of 637 HER2 < 3+ patients). This was not found among ER + PgR- patients (p = 0.186968). Among ER-PgR- patients, HER2 overexpression also increased number of IMA tumor, but by reducing the number of HMA tumors (p < 0.000001). Here, difference between HER2 absent (0+) and HER2 3+ patients was evident (10 HMA out of 125 HER2 3+ patients versus 42 HMA out of 103 HER2 0+ patients). Results suggest that distributions of breast cancers in three clusters of mitotic activity depend on different mechanisms for ER + PgR+ and ER negative tumors. Although HER2 overexpression increases number of IMA tumors in both settings, in the former it is done by reducing number of LMA tumors, while in the latter it reduces the number of HMA tumors. Mitotic activity of ER + PgR- tumors seems unrelated to the HER2 status, possibly as an indicator that ER dysfunctionality in cancers that lack PgR expression. Among ER negative tumors, the absence of HER2 (0+) might be as important as the HER2 overexpression.

1 June 1992 in Neuroscience Letters
Verified
Journal Article
Closed access
BSBoris Sajin
Boris Sajin
NSNenad Sestan
Nenad Sestan
BDBranko Dmitrović
Branko Dmitrović